Colgate-Palmolive Company (CL) — Analysis Summary
Colgate-Palmolive Company (CL) has a market cap of $74.59B with year-over-year revenue growth of +1.4%. Net margin stands at 10.5%. The stock trades at a P/E ratio of 35.7.
Key Takeaways
- Revenue changed +1.4% year-over-year
- Net margin of 10.5%
- P/E ratio of 35.7
Compared to other companies in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS sector, CL posted revenue growth of +1.4% and trades at a P/E of 35.7.
Colgate-Palmolive Company (CL)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
D/E at 16.3x — extreme leverage
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
Sector
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Employees
33,600
Headquarters
NEW YORK, NY
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$2.12
Dividend Yield
2.33%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.